|
Gian-Michele a Marca represents issuers, private equity firms and banks in various financing and corporate transactions, including bank financings, structured financings, convertible and high yield bond offerings, equity offerings and mergers, acquisitions and dispositions. He also represents both issuers and underwriters in initial public offerings of specified purpose acquisition companies ("SPACs") and represents SPACs, investment banks and target companies in business combination transactions by SPACs.
Mr. a Marca's recent deals include:
- Onyx Pharmaceuticals, Inc. – $230 million offering of 4.00% convertible senior notes due 2016 (2009)
- Arena Pharmaceuticals, Inc. – $100 million secured loan transaction (2009)
- Natural Selection Foods – $350 million sale to an entity formed by HM Capital Partners (2009)
- Brocade Communication Systems, Inc. – $1.2 billion senior secured credit facilities to finance the acquisition of Foundry Networks (2008)
- Jazz Technologies, Inc. – $169 million sale to Tower Semiconductor Ltd. (2008)
- Precision Therapeutics, Inc. – $120 million sale to Oracle Healthcare Acquisition Corp. (signed 2007; terminated 2008)
- Exelixis, Inc. – $150 million loan facility (2008)
Mr. a Marca received a J.D. degree, cum laude, in 1996 from Georgetown University Law Center. Mr. a Marca received a Bachelor's degree, cum laude, in Political Science in 1993 from the University of California, Los Angeles, where he received high departmental honors from the Political Science department.
Mr. a Marca is admitted to practice in the states of New York and California.
Mr. a Marca is joined the Firm as a lateral in 2000 and is resident in the San Francisco office.
Education- Georgetown University Law Center
JD, 1996, cum laude - University of California, Los Angeles
BA Political Science, 1993, cum laude
Admissions
|